Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Takeda and Boehringer Ingelheim selected as top pharma employers

The two companies were the only ones to win Top Employer certification for 2023.

By Brian Buntz | January 19, 2023

Top Employers InstituteThe Top Employers Institute has named Takeda (TSE:4502/NYSE:TAK) and privately-held Boehringer Ingelheim to its list of 15 companies to win global Top Employer certification for 2023.

The Top Employers Institute rankings are based on data from its HR Best Practices Survey, which spans 20 topics, including people strategy, work environment, talent acquisition, learning, diversity and inclusion, well-being and other factors.

Takeda has been included in the ranking for six consecutive years. The company scored well in terms of ethics and integrity, purpose and values, business strategy, employer branding, organization and change.

On the employee review site Glassdoor, Takeda’s current ranking was 4.1 out of 5. A total of 82% of workers said they would recommend the company to friends, while 88% approved of CEO Christophe Weber.

[Related: 15 of the best pharma companies to work for]

In its ranking, Top Employers Institute praised Boehringer Ingelheim’s employer benefits and focus on well-being. It also pointed to its positive work environment and rewards and recognition as other factors in its ranking.

On Glassdoor, Boehringer Ingelheim had a current ranking of 4.1. Some 83% of employees said they would recommend the company to a friend. A total of 89% approved of CEO Hubertus von Baumbach.

In a press release, Boehringer Ingelheim highlighted its focus on mental health as a distinguishing factor of its work environment. “Boehringer Ingelheim strives to curb the stigma often experienced by people with mental health conditions as an employer and beyond,” the company noted.

The company also focuses on mental health research that could result in the development of more targeted therapies in the future.

The Top Employers Institute also named Organon China to its list of leading workplaces in greater China. The institute highlighted the company’s culture, diversity and inclusion, branding, work environment and commitment to environmental, social, and corporate governance initiatives.


Filed Under: Drug Discovery and Development
Tagged With: top pharma employers
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbuntz@wtwhmedia.com.

Related Articles Read More >

Collage of close-up male and female eyes isolated on colored neon backgorund. Multicolored stripes. Concept of equality, unification of all nations, ages and interests. Diversity and human rights
How a ‘rising tide’ of inclusivity is transforming clinical trials
Mary Marcus appointed CEO of NewAge Industries
DNA double helix transforming into bar graphs, blue and gold, crisp focus on each strand, scientific finance theme --ar 5:4 --personalize 3kebfev --v 6.1 Job ID: f40101e1-2e2f-4f40-8d57-2144add82b53
Biotech in 2025: Precision medicine, smarter investments, and more emphasis on RWD in clinical trials
Data analytics tools help doctors analyze trends in patient outcomes and population health.
External comparator studies: What researchers need to know to minimize bias
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE